ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025
Tuning the Efficiency of Iridium(III) Complexes for Energy Transfer (EnT) Catalysis through Ligand Design.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Iridium(III) Complexes Bearing Pyrene- and Anthracene-Functionalized Ligands-Photophysics and Application Potential in Photocatalysis, Triplet-Triplet Annihilation Upconversion, Photodynamic Therapy, and Photoactivated Chemotherapy.Molecules (Basel, Switzerland) · 2026Review
- Visible-Light Mediated Activation of 1,3-Dienes and Allenes via Energy Transfers.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Review
- Light-Mediated Binaphthyl Enhanced [2 + 2] Dearomatization of Heterocycles via an Energy-Transfer Process.Organic letters · 2025Article
- Tuning the Efficiency of Iridium(III) Complexes for Energy Transfer (EnT) Catalysis through Ligand Design.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Photoactive Iridium(III) complexes are a popular synthetic tool. The impact of ligand design on their photoredox properties has been widely studied, but similar approaches to develop more potent photosensitizers are still absent. We report herein the preparation, characterization and catalytic application of a new family of Iridium(III) complexes that proved superior to their widely-used commercial peers. The best results were observed when naphthyl pendants were installed to the ligands, which could stabilize the triplet intermediates involved in energy-transfer reactions via radical-π dispersion interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.